Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenue    
Total revenues $ 191,216 $ 56,749
Operating costs and expenses:    
Research and development (629,729) (359,651)
General and administrative (930,578) (927,880)
Total operating costs and expenses (1,560,307) (1,287,531)
Loss from operations (1,369,091) (1,230,782)
Other income (expense):    
Other income (expense) 884 (134)
Interest income 22,262 51,487
Total other income 23,146 51,353
Net loss $ (1,345,945) $ (1,179,429)
Basic and diluted loss per share $ (0.15) $ (0.19)
Weighted-average shares of common stock outstanding, basic and diluted 8,746,263 6,233,331
Royalty [Member]    
Revenue    
Total revenues $ 191,216 $ 56,749